Curis Health Care Investments Ltd. is a limited company established in 2019, operating from its headquarters at 71-75 Shelton Street, London, WC2H 9JQ. The company’s primary focus is on strategic investments within the healthcare sector, specifically concentrating on oncology research and development. Curis Inc. (CRIS) is a significant player in the global cancer landscape, dedicated to advancing innovative therapies and diagnostic tools. The company’s core business involves conducting clinical trials, analyzing data, and collaborating with research institutions to identify and validate novel treatment options. Curis Health Care Investments Ltd. actively seeks opportunities to acquire and develop promising new technologies and intellectual property related to cancer treatment. Currently, Curis operates with a relatively small team and a focus on long-term strategic planning. The company’s activities are primarily centered around research and development, with a strong emphasis on future growth and expansion within the healthcare industry. While currently lacking a significant international presence, Curis Health Care Investments Ltd. is actively pursuing strategic developments to broaden its market reach and enhance its capabilities. The company’s SIC codes include: - 86210: General medical practice activities, - 8711: Pharmaceutical activities, - 8710: Medical device activities, - 8712: Diagnostic activities, - 8713: Clinical research activities, - 8714: Medical device research and development.

Curis Health Care Investments Ltd. is a limited company established in 2019, operating from its headquarters at 71-75 Shelton Street, London, WC2H 9JQ. The company’s primary focus is on strategic investments within the healthcare sector, specifically concentrating on oncology research and development. Curis Inc. (CRIS) is a significant player in the global cancer landscape, dedicated to advancing innovative therapies and diagnostic tools. The company’s core business involves conducting clinical trials, analyzing data, and collaborating with research institutions to identify and validate novel treatment options. Curis Health Care Investments Ltd. actively seeks opportunities to acquire and develop promising new technologies and intellectual property related to cancer treatment. Currently, Curis operates with a relatively small team and a focus on long-term strategic planning. The company’s activities are primarily centered around research and development, with a strong emphasis on future growth and expansion within the healthcare industry. While currently lacking a significant international presence, Curis Health Care Investments Ltd. is actively pursuing strategic developments to broaden its market reach and enhance its capabilities. The company’s SIC codes include: - 86210: General medical practice activities, - 8711: Pharmaceutical activities, - 8710: Medical device activities, - 8712: Diagnostic activities, - 8713: Clinical research activities, - 8714: Medical device research and development.